Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) EBT Margin Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn -
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn 375.00
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn -99.00
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn 1,162.00
5 Bhp 220.99 Bn 202.45 Bn - -
6 Rio Tinto 206.31 Bn 201.93 Bn - -
7 Diageo 192.64 Bn 190.61 Bn - -
8 National Grid 165.59 Bn 161.82 Bn - -
9 Unilever 135.28 Bn 128.25 Bn - -
10 Hdfc Bank 119.43 Bn 82.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -99.00
Mar 31, 2026 432.00
Dec 31, 2025 8,405.00
Sep 30, 2025 1,297.00
Jun 30, 2025 1,932.00
Mar 31, 2025 2,032.00
Dec 31, 2024 1,737.00
Sep 30, 2024 3,408.00
Jun 30, 2024 904.00
Mar 31, 2024 0.00
Dec 31, 2023 184.00
Sep 30, 2023 191.00
Jun 30, 2023 330.00
Mar 31, 2023 659.00
Dec 31, 2022 310.00
Sep 30, 2022 173.00
Jun 30, 2022 -10.00
Mar 31, 2022 -901.00
Dec 31, 2021 -1,819.00
Sep 30, 2021 -2,960.00